Table 5.
Clinical characteristics in age categories ≤50 and >50 years
| ≤50 years, n (%) | >50 years, n (%) | p value | |
|---|---|---|---|
| All GCT | 373 (88.4) | 49 (11.6) | |
| Seminoma | 216 (57.9) | 38 (77.6) | |
| Nonseminoma | 157 (42.1) | 11 (22.5) | 0.0083 |
| Local pathological stage | |||
| pT1 | 196 (52.5) | 26 (53.1) | |
| >pT1 | 177 (47.5) | 23 (46.9) | 0.9460 |
| Local stage seminoma | |||
| pT1 | 129 (59.7) | 21 (55.3) | |
| >pT1 | 87 (40.3) | 17 (44.7) | 0.6062 |
| Local stage nonseminoma | |||
| pT1 | 67 (42.7) | 5 (45.5) | |
| >pT1 | 90 (57.3) | 6 (54.5) | 0.8571 |
| CS distribution (all GCT) | |||
| CS1 | 244 (65.4) | 37 (75.5) | |
| CS2a, b | 87 (23.3) | 8 (16.3) | |
| CS2c | 15 (4.0) | 2 (4.1) | |
| CS3 | 27 (7.2) | 2 (4.1) | 0.5254 |
| CS distribution (seminoma) | |||
| CS1 | 171 (79.2) | 30 (78.9) | |
| CS2a, b | 32 (14.8) | 5 (13.2) | |
| CS2c | 7 (3.2) | 2 (5.3) | |
| CS3 | 6 (2.8) | 1 (2.6) | 0.9326 |
| CS distribution (nonseminoma) | |||
| CS1 | 73 (46.5) | 7 (63.6) | |
| CS2a, b | 55 (35.0) | 3 (27.3) | |
| CS2c | 8 (5.1) | 0 (0) | |
| CS3 | 21 (13.4) | 1 (9.1) | 0.6781 |
| CS1 vs. >CS1 (all GCT) | |||
| CS1 | 244 (65.4) | 37 (75.5) | |
| >CS1 | 129 (34.6) | 12 (24.5) | 0.1590 |
| CS1 vs. >CS1 seminoma | |||
| CS1 | 171 (79.2) | 30 (78.9) | |
| >CS1 | 45 (20.8) | 8 (21.1) | 0.9755 |
| CS1 vs. >CS1 nonseminoma | |||
| CS1 | 73 (46.5) | 7 (63.6) | |
| >CS1 | 84 (53.5) | 4 (36.4) | 0.2712 |
| Nonseminoma with teratoma components | |||
| No teratoma | 82 (52.2) | 6 (54.6) | |
| With teratoma | 75 (47.8) | 5 (45.5) | 0.8818 |
| Tumour right-sided (all GCT) | 175 (49.4) | 26 (55.3) | 0.2943 |
| Tumour right-sided(seminoma) | 108 (52.7) | 21 (58.3) | 0.0821 |
| Tumour right-sided (nonseminoma) | 67 (45.0) | 5 (45.5) | 0.9885 |
GCT, germ cell tumour; CS, clinical stages; pT, pathological.